While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...

A federal judge rejected a bid by compounding pharmacies to continue selling versions of weight-loss drug Wegovy and diabetes ...

No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for bankruptcy. There’s never a dull ...

Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these pharmacies to ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.

Since launching its wildly popular weight-loss drug Wegovy in 2021, Novo Nordisk has raised its annual sales guidance several ...

Novo Nordisk has launched its popular weight-loss drug Wegovy in Thailand, marking its first entry into the Southeast Asian ...

A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...